WASHINGTON, DC – US lawmakers renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid-19 pandemic by India ...
“We intend to carefully examine and analyze the details and consider any necessary responses,” he said. China’s commerce ministry on Wednesday separately launched an anti-dumping probe into the import ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results